Frontiers in Pharmacology | Drugs Outcomes Research and Policies

Perspective

Published on 12 Jan 2023

Advancing evidence-based treatment of infectious diseases in children with real-world data: Opportunities and challenges

in Drugs Outcomes Research and Policies

Kendra K. Radtke
Atul J. Butte

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1054688

2,875 views
1 citation

Original Research

Published on 12 Jan 2023

Treatment attrition rates and relevant risk factors in multiple myeloma: A real-world study in China

in Drugs Outcomes Research and Policies

Wenjiao Tang
Jinrong Yang
Yan Li
Li Zhang
He Li
Jie Wang
Yi Liao
Chunlan Zhang
Ying Qu
Yuhuan Zheng

Frontiers in Pharmacology

doi 10.3389/fphar.2023.979111

4,323 views
5 citations

Correction

Published on 11 Jan 2023

Corrigendum: Formulation and development of transferrin targeted solid lipid nanoparticles for breast cancer therapy

in Drugs Outcomes Research and Policies

Geeta S. Bhagwat
Rajani B. Athawale
Rajeev P. Gude
Shadab Md
Nabil A. Alhakamy
Usama A. Fahmy
Prashant Kesharwani

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1123542

1,317 views

Systematic Review

Published on 10 Jan 2023

Efficacy and safety of concomitant use of proton pump inhibitors with aspirin-clopidogrel dual antiplatelet therapy in coronary heart disease: A systematic review and meta-analysis

in Drugs Outcomes Research and Policies

Xiaofeng Luo
Min Hou
Shuangshuang He
Xue Yang
Pan Zhang
Yingxin Zhao
Haiyan Xing

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1021584

9,755 views
10 citations

Original Research

Published on 10 Jan 2023

Clinical outcomes of dose modification during pirfenidone treatment for IPF: A nationwide post-marketing surveillance study

in Drugs Outcomes Research and Policies

Jieun Kang
Man Pyo Chung
Moo Suk Park
In Jae Oh
Heung Bum Lee
Young Whan Kim
Jong Sun Park
Soo Taek Uh
Yun Seong Kim
Yangjin Jegal

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1025947

4,001 views
7 citations

Clinical Trial

Published on 10 Jan 2023

Investigation of drug-related problems in patients hospitalized in chest disease wards: A randomized controlled trial

in Drugs Outcomes Research and Policies

Muhammed Yunus Bektay
Mesut Sancar
Fatmanur Okyaltirik
Bulent Durdu
Fikret Vehbi Izzettin

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1049289

3,156 views
7 citations

Original Research

Published on 09 Jan 2023

Clinical effectiveness of sodium bicarbonate therapy on mortality for septic patients with acute moderate lactic acidosis

in Drugs Outcomes Research and Policies

Sai Huang
Bo Yang
Yaojun Peng
Qinrui Xing
Lili Wang
Jing Wang
Xuan Zhou
Yuan Yao
Li Chen
Cong Feng

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1059285

5,665 views
2 citations

Editorial

Published on 09 Jan 2023

Editorial: Medication safety and interventions to reduce patient harm in low- and middle-income countries

in Drugs Outcomes Research and Policies

Mansour Adam Mahmoud
Johanna C. Meyer
Ahmed Awaisu
Joseph Fadare
Ahmed Ibrahim Fathelrahman
Fahad Saleem
Hisham Aljadhey
Brian Godman

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1124371

2,128 views

Review

Published on 09 Jan 2023

Immune-mediated hepatitis induced by immune checkpoint inhibitors: Current updates and future perspectives

in Drugs Outcomes Research and Policies

Zherui Liu
Yun Zhu
Huan Xie
Zhengsheng Zou

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1077468

17,365 views
38 citations

Original Research

Published on 04 Jan 2023

The importance of reminders and patient preferences to improve inhaler technique in older adults with COPD

in Drugs Outcomes Research and Policies

P. Barnestein-Fonseca
VM. Cotta-Luque
VP. Aguiar-Leiva
J. Leiva-Fernández
Francisco Martos-Crespo
F. Leiva-Fernández

Frontiers in Pharmacology

doi 10.3389/fphar.2022.989362

4,132 views
7 citations

Original Research

Published on 04 Jan 2023

Cost-effectiveness of fuzuloparib compared to routine surveillance, niraparib and olaparib for maintenance treatment of patients with germline BRCA1/2 mutation and platinum-sensitive recurrent ovarian carcinoma in China

in Drugs Outcomes Research and Policies

Jing Nie
Huina Wu
Lei Sun
Yanjiao Ding
Yepeng Luan
Jiyong Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2022.987337

3,042 views
8 citations

Systematic Review

Published on 23 Dec 2022

Treatment for chemotherapy-induced peripheral neuropathy: A systematic review of randomized control trials

in Drugs Outcomes Research and Policies

Chenkun Wang
Si Chen
Weiwei Jiang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1080888

12,614 views
12 citations

Original Research

Published on 23 Dec 2022

Attitudes and behaviors regarding online pharmacies in the aftermath of COVID-19 pandemic: At the tipping point towards the new normal

in Drugs Outcomes Research and Policies

András Fittler
Tünde Ambrus
Anna Serefko
Lenka Smejkalová
Anna Kijewska
Aleksandra Szopa
Mátyás Káplár

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1070473

16,559 views
34 citations

Original Research

Published on 22 Dec 2022

Flecainide and risk of skin neoplasms: Results of a large nested case–control study in Spain and Denmark

in Drugs Outcomes Research and Policies

Carlen Reyes
Luz M León-Muñoz
Andrea Pistillo
Sigrún Alba Jóhannesdóttir Schmidt
Kasper Bruun Kristensen
Diana Puente
Ana LLorente-García
Consuelo Huerta-Álvarez
Anton Pottegård
Talita Duarte-Salles

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1002451

2,418 views

Clinical Trial

Published on 21 Dec 2022

Efficacy and safety of ciprofol-remifentanil versus propofol-remifentanil during fiberoptic bronchoscopy: A prospective, randomized, double-blind, non-inferiority trial

in Drugs Outcomes Research and Policies

Bin Wu
Wenchao Zhu
Qinghe Wang
Chunguang Ren
Lizhen Wang
Guannan Xie

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1091579

7,139 views
39 citations

Perspective

Published on 20 Dec 2022

An approach to data collection in compassionate use/managed access

in Drugs Outcomes Research and Policies

Séverine Sarp
Ramona Reichenbach
Paul Aliu

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1095860

7,332 views
8 citations